Ward, M., & Foster, D. (2011). CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualisation in H. pylori eradication. European Journal of Clinical Pharmacology, 67(3), 261-267.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Ward, Michael, y David Foster. "CYP2C19-guided Design of a Proton Pump Inhibitor Dose Regimen to Avoid the Need for Pharmacogenetic Individualisation in H. Pylori Eradication."
European Journal of Clinical Pharmacology 67, no. 3 (2011): 261-267.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Ward, Michael, y David Foster. "CYP2C19-guided Design of a Proton Pump Inhibitor Dose Regimen to Avoid the Need for Pharmacogenetic Individualisation in H. Pylori Eradication."
European Journal of Clinical Pharmacology, vol. 67, no. 3, 2011, pp. 261-267.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.